Picton Mahoney Asset Management’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-250,000
Closed -$2.53M 1208
2025
Q1
$2.53M Hold
250,000
0.04% 229
2024
Q4
$2.5M Buy
+250,000
New +$2.5M 0.05% 222

Other funds holding TDACU

Picton Mahoney Asset Management's TDACU Position: Q2 2025 in Review

Picton Mahoney Asset Management sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 250,000 shares — an estimated $2.53M sold.

Picton Mahoney Asset Management first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $2.53M in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Picton Mahoney Asset Management reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 250,000 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $2.53M.
  • Picton Mahoney Asset Management first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Picton Mahoney Asset Management's Translational Development Acquisition Corp Units position peaked at $2.53M in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.